Oncologist-approved cancer information from the American Society of Clinical Oncology
Printer Friendly
Download PDF

Leukemia - Acute Lymphocytic - ALL

This section has been reviewed and approved by the Cancer.Net Editorial Board, 8/2013
Latest Research

Languages

ON THIS PAGE: You will read about the scientific research being done now to learn more about ALL and how to treat it. To see other pages in this guide, use the colored boxes on the right side of your screen, or click “Next” at the bottom.

Doctors are working to learn more about ALL, ways to prevent it, how to best treat it, and how to provide the best care to people diagnosed with this disease. The following areas of research may include new options for patients through clinical trials. Most cancer centers are actively involved in clinical trials aimed at increasing the rate of cure from ALL. Always talk with your doctor about the diagnostic and treatment options best for you.

New drugs and treatment regimens. Researchers are looking at the use of new types of chemotherapy, as well as different schedules and doses of current drugs. The drug clofarabine (Clolar) has been approved for children with recurrent ALL and is being researched for adults with ALL. In addition, several studies have shown that adolescents and younger to middle-aged adults benefit from the more intensive treatments most often used for younger children with ALL.

Immunotherapy. Immunotherapy (also called biologic therapy) is designed to boost the body’s natural defenses to fight the cancer. It uses materials either made by the body or in a laboratory to improve, target, or restore immune system function. Researchers are studying the use of different antibodies directed against ALL cells, including inotuzumab ozogamicin and blinatumomab. Inotuzumab ozogamicin is an antibody joined with a type of chemotherapy to more specifically direct the chemotherapy to the leukemia cell. Blinatumomab is called a bispecific antibody, meaning it is directed against the leukemia cells and helps the patient’s own T cells to attack the leukemia.

Stem cell/bone marrow transplantation. Different ways to make stem cell transplantation (see Treatment) safer and easier are also being studied.

Tests to detect small amounts of ALL after treatment. Researchers are studying other molecular or immunologic tests that can help find small amounts of ALL in patients in remission. Then, a change in treatment may prevent the ALL from coming back.

Supportive care. Clinical trials are underway to find better ways of reducing symptoms and side effects of current ALL treatments in order to improve patients’ comfort and quality of life.

Looking for More about the Latest Research?

If you would like additional information about the latest areas of research regarding leukemia, explore these related items that take you outside of this guide:

To continue reading this guide, choose “Next” (below, right) to see a section about coping with the side effects of the disease or its treatment. Or, use the colored boxes located on the right side of your screen to visit any section.

© 2005-2014 American Society of Clinical Oncology (ASCO). All rights reserved worldwide.

Connect With Us: